Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant mycobacterium tuberculosis strain related to the KZN extensively drug-resistant m. tuberculosis strain from South Africa

Journal of Clinical Microbiology

Volumn 51, Issue 10, 2013, Pages 3277-3285

  Lanzas, Fedora ^a   Karakousis, Petros C ^b   Sacchettini, James C ^c   Ioerger, Thomas R ^d  

^a Instituto Conmemorativo Gorgas de Estudios de la Salud   (Panama)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d Texas AandM University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; KWAZULU NATAL EXTENSIVELY DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANAMA; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOME, BACTERIAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MYCOBACTERIUM TUBERCULOSIS; PANAMA; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84884777242     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01122-13     Document Type: Article

References (51)

1. World Health Organization. 2010. Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global report on surveillance and response. Report WHO/HTM/TB/2010.3. World Health Organization, Geneva, Switzerland.
2. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580. (Pubitemid 44780738)
3. Casali N, Nikolayevskyy V, Balabanova Y, Ignatyeva O, Kontsevaya I, Harris SR, Bentley SD, Parkhill J, Nejentsev S, Hoffner SE, Horstmann RD, Brown T, Drobniewski F. 2012. Microevolution of extensively drugresistant tuberculosis in Russia. Genome Res. 22:735-745.
4. Tang S, Zhang Q, Yu J, Liu Y, Sha W, Sun H, Fan L, Gu J, Hao X, Yao L, Xiao H. 2011. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes. Scand. J. Infect. Dis. 43:280-285.
5. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, Sharp V, Hewlett D, Jr, Brudney K, Alland D, Kreisworth BN. 1996. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276:1229-1235. (Pubitemid 26337705)
6. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849.
7. Mokrousov I, Jiao WW, Sun GZ, Liu JW, Valcheva V, Li M, Narvskaya O, Shen AD. 2006. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob. Agents Chemother. 50:2820-2823. (Pubitemid 44198706)
8. Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung Dis. 14:119-121.
9. Pillay M, Sturm AW. 2007. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin. Infect. Dis. 45:1409-1414. (Pubitemid 351411867)
10. Stavrum R, Myneedu VP, Arora VK, Ahmed N, Grewal HM. 2009. In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi: predominance of drug resistant isolates of the 'modern' (TbD1) type. PLoS One 4:e4540. doi:10.1371/journal.pone.0004540.
11. Hasan R, Jabeen K, Ali A, Rafiq Y, Laiq R, Malik B, Tanveer M, Groenheit R, Ghebremichael S, Hoffner S, Hasan Z. 2010. Extensively drug-resistant tuberculosis, Pakistan. Emerg. Infect. Dis. 16:1473-1475.
12. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR, Jr, Pillay M, Sturm AW, Sacchettini JC. 2009. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4:e7778. doi:10.1371/journal.pone.0007778.
13. Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, Rempel S, Moore R, Zhao Y, Holt R, Varhol R, Birol I, Lem M, Sharma MK, Elwood K, Jones SJ, Brinkman FS, Brunham RC, Tang P. 2011. Wholegenome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 364:730-739.
14. Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, Streicher EM, Warren RM, Gey van Pittius NC, Van Helden PD, Sacchettini JC. 2010. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11:670. doi:10.1186/1471-2164-11- 670.
15. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. 2008. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int. J. Tuberc. Lung Dis. 12:99-104.
16. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, Galagan J, Niemann S, Gagneux S. 2012. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44:106-110.
17. Zazueta-Beltran J, Leon-Sicairos N, Muro-Amador S, Flores-Gaxiola A, Velazquez-Roman J, Flores-Villasenor H, Canizalez-Roman A. 2011. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. Int. J. Infect. Dis. 15:e272-e276. doi:10.1016/j.ijid.2011. 01.001
18. Taype CA, Agapito JC, Accinelli RA, Espinoza JR, Godreuil S, Goodman SJ, Banuls AL, Shaw MA. 2012. Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru. Infect. Genet. Evol. 12:577-585.
19. Brito RC, Mello FC, Andrade MK, Oliveira H, Costa W, Matos HJ, Lourenco MC, Rolla VC, Fonseca L, Ruffino Netto A, Kritski AL. 2010. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Int. J. Tuberc. Lung Dis. 14:24-33.
20. Aristimuno L, Armengol R, Cebollada A, Espana M, Guilarte A, Lafoz C, Lezcano MA, Revillo MJ, Martin C, Ramirez C, Rastogi N, Rojas J, de Salas AV, Sola C, Samper S. 2006. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Antituberculosis Drug Resistance from Venezuela. BMC Microbiol. 6:90. doi: 10.1186/1471-2180-6-90. (Pubitemid 44631335)
21. Baboolal S, Millet J, Akpaka PE, Ramoutar D, Rastogi N. 2009. First insight into Mycobacterium tuberculosis epidemiology and genetic diversity in Trinidad and Tobago. J. Clin. Microbiol. 47:1911-1914.
22. Guernier V, Sola C, Brudey K, Guegan JF, Rastogi N. 2008. Use of cluster-graphs from spoligotyping data to study genotype similarities and a comparison of three indices to quantify recent tuberculosis transmission among culture positive cases in French Guiana during a eight year period. BMC Infect. Dis. 8:46. doi:10.1186/1471-2334-8-46. (Pubitemid 351676568)
23. Candia N, Lopez B, Zozio T, Carrivale M, Diaz C, Russomando G, de Romero NJ, Jara JC, Barrera L, Rastogi N, Ritacco V. 2007. First insight into Mycobacterium tuberculosis genetic diversity in Paraguay. BMC Microbiol. 7:75. doi:10.1186/1471-2180-7-75. (Pubitemid 47460312)
24. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Mokrousov I, Narvskaia O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rusch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMCMicrobiol. 6:23. doi:10.1186/1471-2180-6-23. (Pubitemid 43793192)
25. Rosales S, Pineda-Garcia L, Ghebremichael S, Rastogi N, Hoffner SE. 2010. Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras. BMC Microbiol. 10:208. doi:10.1186/1471-2180-10-208.
26. Molina-Torres CA, Moreno-Torres E, Ocampo-Candiani J, Rendon A, Blackwood K, Kremer K, Rastogi N, Welsh O, Vera-Cabrera L. 2010. Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico. J. Clin. Microbiol. 48:448-455.
27. Petroff SA. 1915. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J. Exp. Med. 21:38-42.
28. Koneman EW. 1988. Color atlas and textbook of diagnostic microbiology, 3rd ed. J. B. Lippincott, Philadelphia, PA.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35: 907-914. (Pubitemid 27146535)
30. Sassetti CM, Rubin EJ. 2003. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100:12989-12994. (Pubitemid 37340013)
31. Lamichhane G, Tyagi S, Bishai WR. 2005. Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect. Immun. 73:2533-2540. (Pubitemid 40470857)
32. Lazzarini LC, Huard RC, Boechat NL, Gomes HM, Oelemann MC, Kurepina N, Shashkina E, Mello FC, Gibson AL, Virginio MJ, Marsico AG, Butler WR, Kreiswirth BN, Suffys PN, Lapa ESJR, Ho JL. 2007. Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil. J. Clin. Microbiol. 45:3891-3902. (Pubitemid 350274867)
33. Isaza JP, Duque C, Gomez V, Robledo J, Barrera LF, Alzate JF. 2012. Whole genome shotgun sequencing of one Colombian clinical isolate of Mycobacterium tuberculosis reveals DosR regulon gene deletions. FEMS Microbiol. Lett. 330:113-120.
34. Chia BS, Lanzas F, Rifat D, Herrera A, Kim EY, Sailer C, Torres-Chavolla E, Narayanaswamy P, Einarsson V, Bravo J, Pascale JM, Ioerger TR, Sacchettini JC, Karakousis PC. 2012. Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama. PLoS One 7:e40456. doi:10.1371/journal.pone.0040456.
35. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. 2004. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J. Med. Microbiol. 53:107-113. (Pubitemid 38223688)
36. Pym AS, Saint-Joanis B, Cole ST. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70:4955-4960.
37. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29. (Pubitemid 29050434)
38. Okamoto S, Tamaru A, Nakajima C, Nishimura K, Tanaka Y, Tokuyama S, Suzuki Y, Ochi K. 2007. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol. Microbiol. 63:1096-1106. (Pubitemid 46188264)
39. Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A. 2008. Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob. Agents Chemother. 52:2947-2949.
40. Wong SY, Lee JS, Kwak HK, Via LE, Boshoff HI, Barry CE, III. 2011. Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2515-2522.
41. Chiu YC, Huang SF, Yu KW, Lee YC, Feng JY, Su WJ. 2011. Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan. BMC Infect. Dis. 11:240. doi:10.1186/1471-2334-11-240.
42. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805. (Pubitemid 37484992)
43. Hirano K, Abe C, Takahashi M. 1999. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol. 37:2663-2666. (Pubitemid 29337295)
44. Moodley P, Shah NS, Tayob N, Connolly C, Zetola N, Gandhi N, Friedland G, Sturm AW. 2011. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa. PLoS One 6:e17513. doi:10.1371/journal. pone.0017513.
45. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946. (Pubitemid 43993719)
46. Sander P, Springer B, Prammananan T, Sturmfels A, Kappler M, Pletschette M, Bottger EC. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-1211. (Pubitemid 34415292)
47. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML. 2009. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 9:39. doi:10.1186/1471-2180-9-39.
48. Marais BJ, Victor TC, Hesseling AC, Barnard M, Jordaan A, Brittle W, Reuter H, Beyers N, van Helden PD, Warren RM, Schaaf HS. 2006. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J. Clin. Microbiol. 44:3539-3543. (Pubitemid 46768796)
49. Chihota VN, Muller B, Mlambo CK, Pillay M, Tait M, Streicher EM, Marais E, van der Spuy GD, Hanekom M, Coetzee G, Trollip A, Hayes C, Bosman ME, Gey van Pittius NC, Victor TC, van Helden PD, Warren RM. 2012. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J. Clin. Microbiol. 50:995-1002.
50. Cooke GS, Beaton RK, Lessells RJ, John L, Ashworth S, Kon OM, Williams OM, Supply P, Moodley P, Pym AS. 2011. International spread of MDRTB from Tugela Ferry, South Africa. Emerg. Infect. Dis. 17:2035-2037.
51. Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. 2012. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa. J. Clin. Microbiol. 50:2857-2862.